PAROLINI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 5.644
AS - Asia 3.186
EU - Europa 2.802
SA - Sud America 427
AF - Africa 65
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 7
Totale 12.149
Nazione #
US - Stati Uniti d'America 5.564
CN - Cina 1.426
SG - Singapore 877
PL - Polonia 761
UA - Ucraina 534
BR - Brasile 363
IT - Italia 334
DE - Germania 281
HK - Hong Kong 257
FR - Francia 209
FI - Finlandia 201
IN - India 168
VN - Vietnam 166
GB - Regno Unito 163
TR - Turchia 93
IE - Irlanda 89
RU - Federazione Russa 81
CA - Canada 48
SE - Svezia 38
BD - Bangladesh 28
AR - Argentina 27
KR - Corea 26
BE - Belgio 23
IQ - Iraq 22
NL - Olanda 19
ZA - Sudafrica 19
AU - Australia 18
JP - Giappone 18
MX - Messico 18
ID - Indonesia 17
ES - Italia 15
MA - Marocco 13
CZ - Repubblica Ceca 11
AT - Austria 10
CO - Colombia 10
EC - Ecuador 10
NG - Nigeria 10
PK - Pakistan 10
SA - Arabia Saudita 10
UZ - Uzbekistan 9
KZ - Kazakistan 8
LT - Lituania 8
MU - Mauritius 7
AZ - Azerbaigian 6
EU - Europa 6
LB - Libano 6
PH - Filippine 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
KE - Kenya 5
GR - Grecia 4
IR - Iran 4
JM - Giamaica 4
JO - Giordania 4
RO - Romania 4
VE - Venezuela 4
DO - Repubblica Dominicana 3
DZ - Algeria 3
HN - Honduras 3
IL - Israele 3
LV - Lettonia 3
AM - Armenia 2
BH - Bahrain 2
CH - Svizzera 2
DK - Danimarca 2
EG - Egitto 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
PS - Palestinian Territory 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
GT - Guatemala 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LS - Lesotho 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
MN - Mongolia 1
NO - Norvegia 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
TJ - Tagikistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 12.149
Città #
Warsaw 760
Fairfield 640
Ashburn 508
Singapore 487
Woodbridge 452
Shenzhen 406
Jacksonville 371
Houston 356
Chandler 296
Cambridge 277
Ann Arbor 269
Hong Kong 254
Seattle 246
Wilmington 229
Beijing 202
San Jose 166
Nanjing 152
Princeton 152
Brescia 150
New York 137
The Dalles 133
Los Angeles 116
Helsinki 107
Dearborn 87
Dublin 87
Lauterbourg 78
Istanbul 63
Nanchang 57
Buffalo 52
Dallas 52
Ho Chi Minh City 50
Munich 48
Jinan 39
Changsha 38
Milan 37
Moscow 36
San Diego 35
Des Moines 34
Shenyang 34
São Paulo 33
London 31
Council Bluffs 30
Tianjin 30
Hanoi 29
Chicago 28
Hebei 27
San Francisco 26
Redondo Beach 25
Shanghai 25
Turku 25
Brussels 20
Dong Ket 20
Montreal 20
Orem 19
Seongnam 19
Santa Clara 17
Tokyo 17
Toronto 16
Verona 16
Zhengzhou 16
Jiaxing 15
Kocaeli 15
Hangzhou 14
Rio de Janeiro 14
Stockholm 14
Brooklyn 13
Genova 13
Indianapolis 13
Kunming 13
Chennai 12
Jakarta 12
Johannesburg 12
Ningbo 12
Augusta 11
Phoenix 11
Taizhou 11
Abuja 10
Changchun 10
Charlotte 10
Denver 10
Frankfurt am Main 10
Manchester 10
Amsterdam 9
Atlanta 9
Brasília 9
Haikou 9
Lanzhou 9
Leawood 9
Mexico City 9
Tashkent 9
Washington 9
Boardman 8
Brno 8
Haiphong 8
Mumbai 8
Poplar 8
Rome 8
Lancaster 7
Lappeenranta 7
Baghdad 6
Totale 8.596
Nome #
Occurrence of nodular lymphocyte-predominant hodgkin lymphoma in hermansky-pudlak type 2 syndrome is associated to natural killer and natural killer T cell defects. 577
A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP 384
Impaired natural killer cell functions in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations 379
NFKB1 regulates human NK cell maturation and effector functions 333
XLP1 inhibitory effect by 2B4 does not affect DNAM-1 and NKG2D activating pathways in NK cells. 295
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 292
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 227
Clinical, laboratory and molecular signs of immunodeficiency in patients with partial oculo-cutaneous albinism. 220
CTLA-4 regulates human Natural Killer cell effector functions 206
The RAC2-PI3K axis regulates human NK cell maturation and function 206
Defective natural killer-cell cytotoxic activity in NFKB2-mutated CVID-like disease 201
Activin A as a Mediator of NK-Dendritic Cell Functional Interactions. 198
Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium. A study of aortic and microvascular endothelial cell lines. 196
A monoallelic activating mutation in RAC2 resulting in a combined immunodeficiency 192
Functional Characterization Of Natural Killer Cells In Type I Leukocyte Adhesion Deficiency 188
Effects of opioid therapy on human natural killer cells. 185
Inherited DOCK2 deficiency in patients with early-onset invasive infections 184
Biological characterization and in vitro effects of human concentrated growth factor preparation: An innovative approach to tissue regeneration 183
2B4 functions as a co-receptor in human NK cell activation 167
Upregulation of urokinase-type plasminogen activator in squamous cell carcinoma of human larynx 166
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content. 154
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer. 154
Selective cross-talk among natural cytotoxicity receptors in human natural killer cells 153
Cellular and molecular pathogenesis of X-linked lymphoproliferative disease. 153
Primitive neuroectodermal tumor in an ovarian cystic teratoma: natural killer and neuroblastoma cell analysis 150
Diagnosing XLP1 in patients with hemophagocytic lymphohistiocytosis. 149
NK cells at the interface between innate and adaptive immunity 142
Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation. 140
X-linked lymphoproliferative disease: the dark side of 2B4 function. 140
Novel insights from adaptor protein 3 complex deficiency 139
Exome sequencing reveals a pallidin mutation in a Hermansky-Pudlak-like primary immunodeficiency syndrome 136
From Natural Killer Cell Receptor Discovery to Characterization of Natural Killer Cell Defects in Primary Immunodeficiencies 134
Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases 132
Basement Membrane Components in Normal, Dysplastic and Neoplastic Epithelia of the Uterine Cervix 132
The role of chemerin in the co-localization of NK and dendritic cell subsets into inflamed tissues. 132
CD59 is physically and functionally associated to Natural Citotoxicity Receptors and activates human NK cell mediated cytotoxicity. 131
Reduced thymic output, increased spontaneous apoptosis and oligoclonal B cells in polyethylene glycol-adenosine deaminase-treated patients 130
Pseudorabies virus US3 protein kinase protects infected cells from NK cell-mediated lysis via increased binding of the inhibitory NK cell receptor CD300a 130
Innate immunity defects in Hermansky-Pudlak type 2 syndrome 129
GPR56 as a novel marker identifying the CD56dull CD16+ Nk cell subset both in blood stream and in inflamed peripheral tissues 129
La sindrome emofagocitica: dai sintomi alle cause genetiche 128
Human natural killer cell receptors and co-receptors 128
NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. 128
Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines 128
Natural killer cell hyporesponsiveness and impaired development in a CD247-deficient patient 128
Severe impairment of IFN-γ and IFN-α responses in cells of a patient with a novel STAT1 splicing mutation. 127
Identification of NKp80, a novel triggering molecule expressed by human NK cells 125
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors 125
Development of chicken embryos exposed to an intermittent horizontal sinusoidal 50 Hz magnetic field. 124
[Distribution of laminin, type IV collagen and fibronectin in normal, dysplastic and neoplastic laryngeal tissue]. 124
Combined immunodeficiency with autoimmunity caused by a homozygous missense mutation in inhibitor of nuclear factor κB kinase alpha (IKKα) 119
NK cells and their receptors during viral infections. 118
CD94 functions as a natural killer cells inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. 116
CARD11 dominant negative mutation leads to altered human Natural Killer cell homeostasis 113
Response to the Letter to the Editor Regarding “Functional evaluation of natural killer cell cytotoxic activity in NFKB-2 mutated patients” 113
Characterization of a new patient with STAT1 deficiency: new insights into IFNs signal transduction pathways 111
P85α is an intrinsic regulator of human natural killer cell effector functions 111
IL21 induces both rapid maturation of human CD34+ cell precursors towards NK cell and acquisition of surface killer Ig-like receptors 110
Identification and Molecular Characterization of NKp30, a Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells. 108
The AZ158 mAb specifically reacts with p70 and p140 inhibitory NK receptors for HLA-B and HLA-A alleles 108
Function and specificity of human natural killer cell receptors. 107
Exome Sequencing Reveals a Pallidin Mutation in a Hermansky-Pudlak-Like Primary Immunodeficiency Syndrome 106
X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells 106
The LIR-1 receptor for the cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles. 102
Triggering Receptors involved in Natural Killer cell mediated cytotoxicity against Choriocarcinomas cells lines 101
IL-12 or IL-4 Prime Human NK Cells to Mediate Functionally Divergent Interaction with Cells or Tumors 100
In vitro treatment with concentrated growth factors (CGF) and sodium orthosilicate positively affects cell renewal in three different human cell lines 100
Natural killer cell impairment in ovarian clear cell carcinoma 98
Linker for Activation of T cells (LAT), a novel immunohistochemical marker for T cells, NK cells, mast cells, and megakaryocytes. Evaluation in normal and pathological conditions 97
Growth advantage and vascularization induced by basic fibroblast growth factor overexpression in endometrial HEC-1-B cells: an export-dependent mechanism of action. 97
Distinctive Lack of CD48 Expression in Subsets of Human Dendritic Cells Tunes Natural Killer Cell Activation 96
Killer cell immunoglobulin-like receptor expression delineates in situ Sezary syndrome lymphocytes 93
Immunohistochemical localization of laminin, collagen IV and fibronectin in dysplasias and neoplasms of the cervix uteri 93
Inhibitory CD94 molecules identified by the Z199 monoclonal antibody recognize different HLA-class I molecules. 93
Cancer stem-like cells in uveal melanoma: novel insights and therapeutic implications 89
Immunocytochemical localization of plasminogen activators in carcinomas in the cervix and vulva. 87
Lack of iNKT Cells and Defects on Differentiation of Dendritic Cells in Patients with Hermansky-Pudlak Type 2 Syndrome (HPS2) 87
Impaired natural and CD16-mediated NK cell cytotoxic function in WAS and XLT patients: ability of IL-2 to correct NK cell functional defect 86
FGF-trapping hampers cancer stem-like cells in uveal melanoma 83
Distribuzione di laminina, collagene di tipo IV e fibronectina nel tessuto laringeo normale, displastico e neoplastico. 83
Lack of DOCK8 impairs the primary biologic functions of human NK cells and abrogates CCR7 surface expression in a WASP-independent manner 81
LAT (Linker for activation of T cells): A novel immunohistochemical marker for T, NK, mast cells and megakaryocytes. Evaluation in normal and pathological conditions. 77
NTB-A, a novel SH2D1A-associated surface molecule contributing to the inability of Natutal Killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease 74
The novel XIAP Lys396Ter variant alters mitochondrial membrane potential and endoplasmic reticulum intensity in monocytes of two XIAP-deficient patients. 21
PD-1+ NK cell subsets in high grade serous ovarian cancer: an indicator of disease severity and a target for combined immunecheckpoint blockade 21
Totale 12.338
Categoria #
all - tutte 51.516
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.516


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021333 0 0 0 0 0 0 0 0 0 130 153 50
2021/2022768 45 146 15 52 16 26 30 42 48 106 53 189
2022/2023787 120 7 14 93 55 216 7 88 105 7 37 38
2023/20241.022 43 10 469 30 28 131 38 44 128 4 9 88
2024/20251.368 13 4 9 187 164 113 112 68 165 75 285 173
2025/20262.783 280 366 277 410 302 198 427 137 204 182 0 0
Totale 12.338